SkinBioTherapeutics (SBTX.LSE) Q4 2024 Earnings

4DecConfirmed
Q4 2022
Q3 2023
Q1 2024
Q4 2024
-0.76
-0.42
-0.09
0.24

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

SkinBioTherapeutics (SBTX.LSE) will report earnings of for Q4 2024 on December 04, 2024.

0 Comments

Share your thoughts